AKT1 and colorectal carcinoma: Improvement of intestinal dysbiosis, increase of Clostridium abundance and fecal butyric acid level, inhibition of microbial butyric acid-mediated PI3K/Akt pathway, induction of apoptosis, attenuation of intestinal inflammation, and reduction of tumor load in CRC.